Francesco Annunziato

Florence, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 137 publications

Safety of Prophylactic Anakinra in Patients Treated with CD28-Based CD19 Chimeric Antigen Receptor-T Cells for R/R B-Cell Lymphoma.

Safety of Prophylactic Anakinra in Patients Treated with CD28-Based CD19 Chimeric Antigen Receptor-T Cells for R/R B-Cell Lymphoma.

Journal: Transplantation and cellular therapy
Published: March 14, 2026

Drug development in systemic sclerosis: novel therapeutics to watch.

Drug development in systemic sclerosis: novel therapeutics to watch.

Journal: Expert review of clinical immunology
Published: February 21, 2026

Modulation of type 2 inflammation during grass pollen-specific sublingual immunotherapy.

Modulation of type 2 inflammation during grass pollen-specific sublingual immunotherapy.

Journal: Frontiers in immunology
Published: January 09, 2026

APL-like subset within NPM1-mutated AML: A distinct immunophenotype correlating with early vascular complications.

APL-like subset within NPM1-mutated AML: A distinct immunophenotype correlating with early vascular complications.

Journal: HemaSphere
Published: September 15, 2025

Combined Minimal Residual Disease Evaluation in Bone Marrow and Apheresis Samples in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation Improves Outcome Prediction.

Combined Minimal Residual Disease Evaluation in Bone Marrow and Apheresis Samples in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation Improves Outcome Prediction.

Journal: Cancers
Published: May 23, 2025

Diagnostic Performance of Three Serological Assays in Myasthenia Gravis: A Prospective Multicentre Study.

Diagnostic Performance of Three Serological Assays in Myasthenia Gravis: A Prospective Multicentre Study.

Journal: Scandinavian journal of immunology
Published: May 11, 2025

Downregulation of CD19 Expression Associates With Mantle Cell Lymphoma Relapse Following CAR-T Cell Therapy.

Downregulation of CD19 Expression Associates With Mantle Cell Lymphoma Relapse Following CAR-T Cell Therapy.

Journal: European journal of immunology
Published: April 30, 2025

DNA methylation profiling of human CD4+ T helper cells reveals the epigenetic control of SLAMF7 expression in IFN-γ producing cells.

DNA methylation profiling of human CD4+ T helper cells reveals the epigenetic control of SLAMF7 expression in IFN-γ producing cells.

Journal: Immunology and cell biology
Published: April 29, 2025

Impact of baseline genetic profile and treatment on outcome and hematological toxicity in CEBPA-mutated AML.

Impact of baseline genetic profile and treatment on outcome and hematological toxicity in CEBPA-mutated AML.

Journal: Blood cancer journal
Published: December 17, 2024

5-ALA Assisted Surgery of Human Glioblastoma Samples Reveals an Enrichment of T Cells Expressing PD-1 and CD103 in the Intermediate and Marginal Layers.

5-ALA Assisted Surgery of Human Glioblastoma Samples Reveals an Enrichment of T Cells Expressing PD-1 and CD103 in the Intermediate and Marginal Layers.

Journal: European journal of immunology
Published: November 22, 2024

CD3+CD4-CD8- Double-Negative Lymphocytes Are Increased in the Aqueous Humor of Patients with Retinitis Pigmentosa: Their Possible Role in Mediating Inflammation.

CD3+CD4-CD8- Double-Negative Lymphocytes Are Increased in the Aqueous Humor of Patients with Retinitis Pigmentosa: Their Possible Role in Mediating Inflammation.

Journal: International journal of molecular sciences
Published: October 20, 2024

Seasonal patterns of myositis-specific and myositis-associated autoantibodies in Italy: Seasonal patterns of myositis autoantibodies.

Seasonal patterns of myositis-specific and myositis-associated autoantibodies in Italy: Seasonal patterns of myositis autoantibodies.

Journal: Immunology letters
Published: September 09, 2024
Showing 1-12 of 137

Last Updated: 09/26/2026